2210 related articles for article (PubMed ID: 8319494)
1. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
[TBL] [Abstract][Full Text] [Related]
2. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
[TBL] [Abstract][Full Text] [Related]
3. Characterization of gangliosides in human uveal melanoma cells.
Soulieres D; Rousseau A; Deschenes J; Tremblay M; Tardif M; Pelletier G
Int J Cancer; 1991 Oct; 49(4):498-503. PubMed ID: 1917148
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides in human uveal melanoma metastatic process.
Tardif M; Coulombe J; Soulières D; Rousseau AP; Pelletier G
Int J Cancer; 1996 Sep; 68(1):97-101. PubMed ID: 8895547
[TBL] [Abstract][Full Text] [Related]
5. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
Ma D; Luyten GP; Luider TM; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
[TBL] [Abstract][Full Text] [Related]
6. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
8. Role of fas ligand in uveal melanoma-induced liver damage.
Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
[TBL] [Abstract][Full Text] [Related]
9. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice.
Wang S; Coleman EJ; Pop LM; Brooks KJ; Vitetta ES; Niederkorn JY
Int J Cancer; 2006 Feb; 118(4):932-41. PubMed ID: 16152588
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.
Ravindranath MH; Muthugounder S; Presser N
Melanoma Res; 2008 Feb; 18(1):47-55. PubMed ID: 18227708
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice.
Katano M; Irie RF
Immunol Lett; 1984; 8(4):169-74. PubMed ID: 6542067
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
Labialle S; Dayan G; Gambrelle J; Gayet L; Barakat S; Devouassoux-Shisheboran M; Bernaud J; Rigal D; Grange JD; Baggetto LG
Melanoma Res; 2005 Aug; 15(4):257-66. PubMed ID: 16034303
[TBL] [Abstract][Full Text] [Related]
13. Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.
Yu J; Wu X; Yan J; Yu H; Xu L; Chi Z; Sheng X; Si L; Cui C; Dai J; Ma M; Xu T; Kong Y; Guo J
J Hematol Oncol; 2018 Jan; 11(1):1. PubMed ID: 29298689
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.
Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV
BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917
[TBL] [Abstract][Full Text] [Related]
15. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
[TBL] [Abstract][Full Text] [Related]
16. Polysialogangliosides expressed by amelanotic melanoma: a possible explanation for the poor response to anti-monosialoganglioside antibody 202 in a patient with melanoma.
Hamanaka S; Ota T; Asagami C; Gondo T; Yamaguchi Y; Tai T; Kawashima I; Irie RF; Otsuka F
J Dermatol; 1995 Feb; 22(2):81-7. PubMed ID: 7722094
[TBL] [Abstract][Full Text] [Related]
17. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
18. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
19. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases.
Apte RS; Niederkorn JY; Mayhew E; Alizadeh H
Arch Ophthalmol; 2001 Dec; 119(12):1805-9. PubMed ID: 11735791
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides.
Iliopoulos D; Ernst C; Steplewski Z; Jambrosic JA; Rodeck U; Herlyn M; Clark WH; Koprowski H; Herlyn D
J Natl Cancer Inst; 1989 Mar; 81(6):440-4. PubMed ID: 2918552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
